Molecular Profiling of Metastatic Cancer in Pleural Effusion and Ascites
1 other identifier
observational
20
1 country
1
Brief Summary
Cancers are among the most frequent leading causes of death in Taiwan, and many of them show their respective unique epidemiological and pathophysiological features in Taiwanese population. One of the distinguishing features of cancers includes their potential to metastasize outside the primary tumor. Pleural cavity and peritoneum are two of the most frequent sites of metastases when serosal surfaces are involved. The prognoses of such patients are extremely poor with a median survival of months. The understandings of cancer biology of tumor metastasis demand more in-depth studies at the molecular and cell levels. Studies based on cell culture are excellent approaches for this purpose as the cell culture provides a relevant and renewable model for studying the pathological and molecular changes underlying human malignant tumors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2011
CompletedFirst Submitted
Initial submission to the registry
June 8, 2011
CompletedFirst Posted
Study publicly available on registry
June 9, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2013
CompletedJune 9, 2011
June 1, 2011
June 8, 2011
June 8, 2011
Conditions
Keywords
Eligibility Criteria
cancer patients
You may qualify if:
- cancer patients
- pleural effusion or peritoneal effusion
You may not qualify if:
- infected and fever patients
- anticoagulant treatment patients
- patients don't attend this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Taipei Medical University - WanFang Hospital
Taipei, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tze-Sian Chan
Taipei Medical University WanFang Hospital
Study Design
- Study Type
- observational
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
June 8, 2011
First Posted
June 9, 2011
Study Start
May 1, 2011
Study Completion
May 1, 2013
Last Updated
June 9, 2011
Record last verified: 2011-06